[HTML][HTML] Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology

HH Uhlig, BS McKenzie, S Hue, C Thompson… - Immunity, 2006 - cell.com
HH Uhlig, BS McKenzie, S Hue, C Thompson, B Joyce-Shaikh, R Stepankova, N Robinson…
Immunity, 2006cell.com
The CD40-CD154 pathway is important in the pathogenesis of inflammatory bowel disease.
Here we show that injection of an agonistic CD40 mAb to T and B cell-deficient mice was
sufficient to induce a pathogenic systemic and intestinal innate inflammatory response that
was functionally dependent on tumor necrosis factor-α and interferon-γ as well as interleukin-
12 p40 and interleukin-23 p40 secretion. CD40-induced colitis, but not wasting disease or
serum proinflammatory cytokine production, depended on interleukin-23 p19 secretion …
Summary
The CD40-CD154 pathway is important in the pathogenesis of inflammatory bowel disease. Here we show that injection of an agonistic CD40 mAb to T and B cell-deficient mice was sufficient to induce a pathogenic systemic and intestinal innate inflammatory response that was functionally dependent on tumor necrosis factor-α and interferon-γ as well as interleukin-12 p40 and interleukin-23 p40 secretion. CD40-induced colitis, but not wasting disease or serum proinflammatory cytokine production, depended on interleukin-23 p19 secretion, whereas interleukin-12 p35 secretion controlled wasting disease and serum cytokine production but not mucosal immunopathology. Intestinal inflammation was associated with IL-23 (p19) mRNA-producing intestinal dendritic cells and IL-17A mRNA within the intestine. Our experiments identified IL-23 as an effector cytokine within the innate intestinal immune system. The differential role of IL-23 in local but not systemic inflammation suggests that it may make a more specific target for the treatment of IBD.
cell.com